Blog

Blog - Most recent

One year on at the EMEA Johnson & Johnson Innovation Centre in London: Nurturing Great Ideas Wherever They Come From

By Sir Harpal Kumar

Full article

The power of industry collaboration – Johnson & Johnson collaborates with government, world-leading research charity and industry in ground-breaking Whole Genome Sequencing project

By Nerida Scott

Full article

The Road Less Traveled: Honoring 2018 Dr. Paul Janssen Award Winner James Allison

Full article

Harnessing the Best Healthcare Innovations : Q&A with Michal Preminger, Ph.D., MBA, Head of Johnson & Johnson Innovation, Boston

By Erin Walsh

Full article

New Dr. Paul Janssen Project Catalyzes and Convenes Champions of Science Across Generations and Geographies

By Seema Kumar

Johnson & Johnson recently launched the Dr. Paul Janssen Project –a multi-faceted public engagement
Full article

Proud to Support “Together Science Can”

By Emma Kohring

*/ /*-->*/ Science is built on collaboration, partnership, sharing and ideas. Science can solve some
Full article

Illuminating the Future of Medical Devices

By JLABS

A new generation of medical device technologies is spurring incredible progress across the health
Full article

For Breakthrough Innovation, Follow the Big Needs not the Existing Solutions

By JLABS

For Breakthrough Innovation, Follow the Big Needs not the Existing Solutions By Partha Ray, Director
Full article

JJDC participates in launch of Inivata – a company focused on innovative “liquid biopsy” technology aimed at transforming cancer treatment.

Technological advances with the potential to support more informed clinical decisions are vitally
Full article

Three Of Our Collaborating Companies Make Fierce Biotech’s 2014 Fierce 15 List

Today, Fierce Biotech published its 2014 Fierce 15 list, the 12 th annual review of the top 15
Full article

The Potential Power of Better Insulin-Producing Cells for Type 1 Diabetes Treatment

Today, a study published in Nature Biotechnology outlined a “recipe” for creation of insulin
Full article

Biocartis Raises €64.5 Million

New technologies in the form of sophisticated molecular diagnostic tools are needed to advance the
Full article